Tab. II.
Distinct genetic alterations in type I and type II endometrial cancer (percentage is based on several publications, showing only a general tendency) [24–26]
Mutation | Type I | Type II |
---|---|---|
PTEN | 50-80% | 1-10% |
KRAS | 20-40% | 4-8% |
CTNNB1 | 25% | uncommon |
PIK3CA | 40-50% | 20-40% |
PIK3R1 | 20-40% | < 10% |
ARID1A | 25-50% | 5-10% |
TP53 | 10% | 80-90% |
HER2 | very uncommon | 30-40% |
MSI | 30-40% | uncommon |
PPP2R1A | < 10% | 10-40% |